Pramipexole Dihydrochloride Hydrate Transdermal Patch(Guangdong Hongshanhu Pharma)

普拉克索透皮贴剂（广东红珊瑚药业）

Report date: 2025/08/01 15:43:26

Base Information

Drug NamePramipexole Dihydrochloride Hydrate Transdermal Patch(Guangdong Hongshanhu Pharma)
Drug Alias NamePramipexol普拉克索盐酸水合物Sirfrol ER盐酸普拉克索水合物Pramipexolum +[10] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDopamine D3 receptor agonistsDopamine D4 receptor agonistsDopamine D2 receptor agonists
TargetsDopamine D2 receptorDopamine D4 receptorDopamine D3 receptor
Therapy Area/IndicationsParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesGuangdong Hongshanhu Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesGuangdong Hongshanhu Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsParkinson Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksWikipediaDrugBankKEGG